Co-Chairs: Mohan Krishnamachary, MD, and Kristin Higgins, MD
10:15 AM
Beyond PACIFIC in Stage III NSCLC
Ticiana Leal, MD
10:35 AM
Consolidation RT in Oligometastatic NSCLC
Sibo Tian, MD
10:55 AM
DEBATE: Targeted Therapy in Stage III NSCLC – Yes or No?
Yes: Jyoti D. Patel, MD
No: Stephen Liu, MD
11:35 AM
Panel Discussion
11:55 AM
Lunch Symposium
Plenary 3: Immunotherapy in Advanced NSCLC
Co-Chairs: William Jonas, MD, and Jennifer Carlisle, MD
12:45 PM
Updates in Frontline Immunotherapy in NSCLC
Paul Bunn, MD
1:05 PM
Emerging Strategies in IO-Resistant NSCLC
Ticiana Leal, MD
1:25 PM
Novel Treatment Approaches in SCLC
Taofeek Owonikoko, MD, PhD
1:45 PM
Panel Discussion
2:05 PM
Afternoon Break and Exhibits
Plenary 4: Targeted Therapies in Advanced NSCLC
Co-Chairs: Paul Gill, MD, and Michael Andrews, MD
2:25 PM
Updates in EGFR NSCLC
Suresh Ramalingam, MD, FACP, FASCO
2:40 PM
EGFR Exon 20 and EGFR Uncommon Mutations in NSCLC
Jennifer W. Carlisle, MD
2:55 PM
KRAS NSCLC and Combinations to Overcome Resistance
John V. Heymach, MD, PhD
3:10 PM
ALK/HER2 NSCLC
Conor E. Steuer, MD
3:25 PM
BRAF/RET/MET NSCLC
Ibiayi Dagogo-Jack, MD
3:40 PM
Panel Discussion
3:55 PM
Closing Remarks and Adjourn
We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.